| Platelet Intracellular Calcium and the Response to
Serotonin as a Peripheral Marker in Mood Disorders (M. Berk).
Stress, Glucocorticoids and Depression: Implications for
Pharmacological Intervention (T. Dinan).
Measuring Cholinergic Function and Cognitive Abilities (W.
Riedel, et al.).
Assessing Sedating and Alerting Drug Effects: The Multiple Sleep
Latency Test (T. Roth & T. Roehrs).
Actigraphy in Psychopharmacology (N. Stanley).
Cognitive Testing of New Anticonvulsants (M. Trimble).
Vascular Dementia: Diagnosis and Management (K. Amar & G.
Wilcock).
Quality of Life in Psychopharmacology: What are We Measuring and
Why Does it Matter?
(C. Selai & M. Trimble).
Drug Regulation and Psychopharmacology: Measures and Methods (D.
Jefferys).
Assessing Accident Risk Potential for Psychoactive Drugs (C. Dal
Pozzo).
Legal Aspects of Drugs in the Workplace (G. Howard).
Withdrawal of Psychotropic Drugs from the Market: I: From
Thalidomide to Zimeldine (J. Edwards).
Withdrawal of Psychotropic Drugs from the Market: II: From
Nomifensine to Remoxipride (J. Edwards).
Index. |
